An Initial Study of the Implementation of Digital Therapeutics for Substance Use Disorders in Primary Care
DIGITS Pilot
Digital Therapeutics for Opioids and Other Substance Use Disorders in Primary Care Pilot (DIGITS Trial Pilot)
2 other identifiers
interventional
1,552
1 country
1
Brief Summary
The DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders in primary care. In this pilot study, the FDA-authorized reSET and reSET-O digital therapeutics will be implemented in 2 primary care clinics as part of quality improvement. The pilot is comprised of a 3-month period in which a standard approach to implementing reSET and reSET-O is applied in the two primary care clinics "standard implementation", followed by a second 3-month period in which the study will test and refine the two experimental implementation strategy interventions, health coaching (patient-facing) and practice coaching (clinician-facing) in the same clinics. This study will also pilot economic data collection tools and collect qualitative data for a formative evaluation. The analytic goals are to inform the statistical design and data collection processes for the subsequent cluster-randomized DIGITS Trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 6, 2021
CompletedFirst Submitted
Initial submission to the registry
May 25, 2021
CompletedFirst Posted
Study publicly available on registry
May 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 4, 2023
CompletedResults Posted
Study results publicly available
August 6, 2025
CompletedAugust 6, 2025
July 1, 2025
2.6 years
May 25, 2021
April 28, 2025
July 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Reach of the Digital Therapeutic to Patients in the Primary Care Clinic
The proportion of patients who initiate the digital therapeutic, defined by instances in which patients open the app, enter the prescription code, and use a treatment module
6 months
Fidelity of Patients Use of the Digital Therapeutic to Clinical Recommendations
Mean number of weeks in which patients use 4 app modules/week and have visited a clinician in the past month
9 months
Secondary Outcomes (1)
Effectiveness
9 months
Other Outcomes (4)
Reach-3
6 months
Reach-2
6 months
Fidelity-2
9 months
- +1 more other outcomes
Study Arms (2)
Standard Implementation Plus Health Coaching
EXPERIMENTALThe clinic in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O.
Standard Implementation Plus Health Coaching and Practice Facilitation
EXPERIMENTALThe clinic in this arm will implement reSET and reSET-O with a standard implementation strategy and patients at the clinic will receive support from a health coach to help them engage with reSET and reSET-O. Additionally, a practice facilitator will provide the clinic with support for implementation.
Interventions
The clinic is provided access to a health coach who conducts outreach with patients. The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.
In the context of a supportive relationship, a trained facilitator delivers the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.
Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.
Eligibility Criteria
You may qualify if:
- Had a primary care visit in a participating clinic during the pilot
- Screened positive for substance use
- Adult aged 18 years or older at time of visit
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Permanentelead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Kaiser Permanente Washington
Seattle, Washington, 98101, United States
Related Publications (1)
Mogk J, Idu AE, Bobb JF, Key D, Wong ES, Palazzo L, Stefanik-Guizlo K, King D, Beatty T, Dorsey CN, Caldeiro RM, Garza McWethy A, Glass JE. Prescription Digital Therapeutics for Substance Use Disorder in Primary Care: Mixed Methods Evaluation of a Pilot Implementation Study. JMIR Form Res. 2024 Sep 2;8:e59088. doi: 10.2196/59088.
PMID: 39222348DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Joseph E Glass, PhD
- Organization
- Kaiser Permanente Washington Health Research Institute
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph E Glass, PhD, MSW
Kaiser Permanente
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2021
First Posted
May 28, 2021
Study Start
May 6, 2021
Primary Completion
December 4, 2023
Study Completion
December 4, 2023
Last Updated
August 6, 2025
Results First Posted
August 6, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share